Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 8 Other hematologic neoplasm 2 Lymphoid 2 Gynecologic 2 Gastrointestinal 2 Breast 2 Thoracic 1 Sarcoma 1 Other 1 Head & Neck 1 Genitourinary 1 CNS 1

Conditions

Lung Neoplasms 25 Carcinoma, Non-Small-Cell Lung 10 Colorectal Neoplasms 5 Breast Neoplasms 5 Colonic Neoplasms 4 Rectal Neoplasms 3 Prostatic Neoplasms 3 Urinary Bladder Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Anxiety Disorders 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Tobacco Use Disorder 1 Stress Disorders, Post-Traumatic 1 Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Respiration Disorders 1 Pain 1 Ovarian Neoplasms 1 Motor Activity 1 Melanoma 1 Lymphoma 1 Heart Diseases 1 Esophageal Neoplasms 1 Digestive System Neoplasms 1 Depression 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1

Interventions

pembrolizumab 92 Nivolumab 57 Cyclophosphamide 22 Ipilimumab 17 atezolizumab 15 Magnetic Resonance Spectroscopy 14 Specimen Handling 13 Radiosurgery 13 Paclitaxel 13 Interleukin-2 12 Docetaxel 12 fludarabine 11 Carboplatin 11 Pemetrexed 10 spartalizumab 9 Biopsy 9 durvalumab 8 Cisplatin 8 Radiotherapy 7 Immune Checkpoint Inhibitors 7 Blood Specimen Collection 7 cemiplimab 6 avelumab 6 aldesleukin 6 Taxes 6 Gemcitabine 6 Drug Therapy 6 Bevacizumab 6 trametinib 5 tislelizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × Methods × Thoracic × Clear all

NCT04193956 2024-05-03

POINTING

University Medical Center Groningen

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡